×

We've got news for you.

Register on BusinessLIVE at no cost to receive newsletters, read exclusive articles & more.
Register now

Labat Africa, an investment company looking to take advantage of rising demand for cannabis-derived products, has started recruiting people for its first clinical cannabis trial in SA.

Labat’s East London research subsidiary Biodata will run the Pharma Ethics Observational Study in order to test whether cannabis can replace opioids for managing chronic pain, the company said in a statement on Tuesday...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now